f.espinoza
TL2 Moderator · Braga
Contributes reviews on supplier material. Based in Braga.
Joined 24 July 2025 · last posted 5d
91 posts, newest first. Showing up to 150.
-
What is genuinely unknown about long-term amylin agonism Replied, post #74 · Compounds › Cagrilintide & amylin analogues · 23 Jul 2026 · 19 likes This follows post #71 rather than contradicting it. The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The…
-
[2026 update] Documenting an adverse event properly Replied, post #17 · Safety › Adverse events · 22 Jul 2026 · 16 likes How to document: date, exact symptom or event, severity, duration, outcome, any medical attention sought. Detailed documentation is far more useful than a vague report.
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #79 · Practice › Dosing & titration · 19 Jul 2026 · 1 like How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
Travelling with an injectable: documentation and practicalities Replied, post #41 · Access › International · 18 Jul 2026 · 4 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #88 · Start Here › Welcome · 17 Jul 2026 · 6 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
-
What would change my mind about repair peptides: a specific answer Replied, post #25 · Compounds › Repair & healing peptides · 16 Jul 2026 · 9 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
Why the cheapest option is often not the cheapest Replied, post #14 · Access › Pricing · 29 Jun 2026 · 4 likes International pricing: the same compound costs very different amounts in different countries because healthcare systems and regulatory frameworks differ. Generally, US…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #69 · Wellbeing › Sleep · 26 Jun 2026 · 3 likes Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy deficit because stress and sleep need are higher.
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #71 · Practice › Interactions · 25 Jun 2026 · 0 likes This follows post #68 rather than contradicting it. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to…
-
Revisiting: Protein density versus volume when you cannot eat much Started this topic · Nutrition & Training › Protein & intake · 21 Jun 2026 · 4 likes Revisiting: Protein density versus volume when you cannot eat much Writing it up because I had to work it out twice and would rather nobody else did. Longitudinal…
-
Why the timeline is on the right and not the left — what changed since Replied, post #57 · Meta › Site feedback · 18 Jun 2026 · 14 likes Feature requests: if the site would work better with a feature it does not have (better search, different filtering, new section) suggest it here with the reasoning.
-
Why side effects reset at each escalation and that is not a failure Started this topic · Practice › Side effects · 14 Jun 2026 · 0 likes Why side effects reset at each escalation and that is not a failure — that is the question, and I have not found it answered plainly anywhere I have looked. I have read…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #27 · Practice › Side effects · 13 Jun 2026 · 0 likes I read post #25 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Racemisation and why it is invisible to a mass measurement Replied, post #64 · Analytics › Impurities & related substances · 12 Jun 2026 · 14 likes Truncation products: fragments from incomplete synthesis or from degradation. They elute quite differently from the intact peptide because they are much smaller and…
-
About the Adverse events category Replied, post #3 · Safety › Adverse events · 7 Jun 2026 · 5 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #3 · Analytics › Home & field testing · 5 Jun 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Replied, post #13 · Evidence › Journal club · 3 Jun 2026 · 5 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Review: an evidence digest and the citation check that delayed it Replied, post #9 · Documentation › Doc review · 2 Jun 2026 · 1 like Picking up post #6: that is the part I would want checked first. Evidence synthesis requests: if you think a page should summarise the state of evidence on a question,…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #104 · Clinical › Bloodwork · 27 May 2026 · 0 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
Reading a home test result without over-claiming Replied, post #36 · Analytics › Home & field testing · 9 May 2026 · 31 likes Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #103 · Sourcing › Vendor reports · 4 May 2026 · 26 likes post #102 answers the question as asked. The question underneath it is different. Structured report format: compound, lot, independent testing service, method as…
-
Coming back to: A newcomer's list of things that confused me, and the fixes Replied, post #5 · Start Here › Welcome · 18 Apr 2026 · 29 likes post #4 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #6 · Practice › Reconstitution · 17 Apr 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
List price versus negotiated price versus what you pay Replied, post #11 · Access › Pricing · 8 Apr 2026 · 6 likes Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and prices might fall. That has already happened for some…
-
Journal club: is percentage weight change the right endpoint? Replied, post #44 · Evidence › Journal club · 6 Apr 2026 · 2 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
When a dose reduction is the correct response to a side effect Replied, post #8 · Practice › Dosing & titration · 27 Mar 2026 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #87 · Practice › Storage & stability · 25 Mar 2026 · 0 likes Coming back to post #85, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Revisiting: Maintainer handover: how it works Replied, post #51 · Meta › Wiki maintenance · 14 Mar 2026 · 16 likes post #50 is right about the mechanism and I think understates the practical bit. Revision disputes: if you disagree with an edit a maintainer made, discussing it here…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #60 · Pharmacology › Pharmacokinetics · 4 Mar 2026 · 15 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
-
GLP-1 receptor distribution: central and peripheral Replied, post #11 · Pharmacology › Receptor biology · 4 Mar 2026 · 13 likes Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways over others) and can desensitise over time (responding less to the…
-
Follow-up: Search filters: what is missing Replied, post #44 · Meta › Site feedback · 2 Mar 2026 · 2 likes Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to you, report it. Accessibility matters.
-
Measurement error in a self-reported exposure Replied, post #101 · Evidence › Study critique · 26 Feb 2026 · 0 likes Worth separating two things that post #97 runs together. Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes…
-
Measurement error in a self-reported exposure Replied, post #98 · Evidence › Study critique · 26 Feb 2026 · 24 likes post #97 answers the question as asked. The question underneath it is different. Publication bias: a single published positive trial is weaker evidence than multiple…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Started this topic · Clinical › Comorbidities · 18 Feb 2026 · 43 likes Revisiting: PCOS and metabolic overlap: what is and is not studied — setting out what I have, and where I think it stops being reliable. Asking about a population…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #64 · Practice › Storage & stability · 10 Feb 2026 · 4 likes post #63 answers the question as asked. The question underneath it is different. Container choice matters: the material of the vial, the rubber closure, the fill volume…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #44 · Practice › Dosing & titration · 18 Jan 2026 · 30 likes Picking up post #41: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Absence of evidence and evidence of absence Replied, post #13 · Research Methods › Statistics · 15 Jan 2026 · 1 like Confounding: a third variable explains an apparent association. In randomised data, randomisation balances confounders. In observational data, confounders can be…
-
Injection volume, overload, and peak distortion — one year on Replied, post #3 · Analytics › HPLC & UHPLC · 14 Jan 2026 · 3 likes I read the opening post twice before replying, because I had assumed the opposite. On integration: where the baseline is drawn matters more than most people realise. On…
-
A partial dose because the pen emptied mid-injection Replied, post #54 · Practice › Administration · 9 Jan 2026 · 14 likes I read post #52 twice before replying, because I had assumed the opposite. Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not…
-
Aggregates and why a purity assay may miss them entirely Replied, post #36 · Analytics › Impurities & related substances · 29 Dec 2025 · 0 likes Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting pair. It is a chemical modification that occurs during storage.
-
The headache that turns out to be dehydration Replied, post #84 · Nutrition & Training › Hydration & electrolytes · 6 Dec 2025 · 27 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Lurking for two months before posting: was that the right call? Replied, post #32 · Start Here › Welcome · 18 Nov 2025 · 29 likes Picking up post #29: that is the part I would want checked first. The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not…
-
Lipase elevation without symptoms: the interpretation problem Replied, post #14 · Clinical › Bloodwork · 18 Nov 2025 · 1 like Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down the cause. Multiple markers together are more…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #106 · Start Here › How to Ask · 17 Nov 2025 · 31 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
[2026 update] What steady state means for the decision to escalate Replied, post #104 · Practice › Dosing & titration · 15 Nov 2025 · 27 likes On post #100 — agreed on the reasoning, with one qualification. Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The…
-
EMA product information as a primary source Replied, post #46 · Regional › European Union · 9 Nov 2025 · 17 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #19 · Compounds › Tirzepatide · 8 Nov 2025 · 0 likes post #18 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
MHRA statements, read directly Replied, post #27 · Regional › UK & Ireland · 6 Nov 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Gauge and length selection for subcutaneous injection Replied, post #47 · Devices › Syringes & needles · 5 Nov 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: Absolute versus relative contraindications Replied, post #4 · Safety › Contraindications · 3 Nov 2025 · 4 likes Picking up the opening post: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #79 · Documentation › Doc review · 22 Oct 2025 · 0 likes Coming back to post #77, because the follow-up matters more than the original answer. Review of promoted topics: when a topic is nominated for promotion to a maintained…
-
New subcategory: rationale and scope Replied, post #41 · Meta › Announcements · 17 Oct 2025 · 16 likes This follows post #38 rather than contradicting it. Implementation timeline: announcements include when a change takes effect. Marking the date helps you know whether…
-
Persistent vomiting and the threshold for seeking help Replied, post #51 · Safety › Adverse events · 15 Oct 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Managing an unplanned gap in supply — what changed since Replied, post #79 · Access › Shortages · 4 Oct 2025 · 15 likes Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are and following their communication is useful.
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #16 · Lounge › Off topic · 2 Sep 2025 · 16 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
-
[2026 update] Splitting an overlong document into two Replied, post #27 · Documentation › Wiki requests · 25 Aug 2025 · 3 likes Worth separating two things that post #23 runs together. Suggesting content for a page: if you know a maintained page is missing something important, post a suggestion…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #117 · Practice › Reconstitution · 16 Aug 2025 · 30 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
-
[2026 update] Long-time reader, first-time poster Replied, post #3 · Lounge › Introductions · 3 Aug 2025 · 0 likes Following up: if you introduce yourself and someone asks a follow-up question, you can reply here or in a direct message depending on what feels right.
-
A ten-fold dose error caught before injection — one year on Replied, post #51 · Devices › Syringes & needles · 2 Aug 2025 · 0 likes On post #47 — agreed on the reasoning, with one qualification. Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for…
-
Comparing the STEP programme populations: who was actually enrolled — the long version Replied, post #3 · Compounds › Semaglutide · 1 Aug 2025 · 4 likes post #2 is right about the mechanism and I think understates the practical bit. The opalescent appearance in semaglutide solutions is occasionally noted and the…
-
Coming back to: Official shortage notices and what they authorise Replied, post #69 · Access › Shortages · 26 Jul 2025 · 11 likes On post #65 — agreed on the reasoning, with one qualification. Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #88 · Practice › Reconstitution · 16 Jul 2025 · 16 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #18 · Compounds › Semaglutide · 24 Jun 2025 · 5 likes Picking up post #15: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #72 · Wellbeing › Mental health · 18 Jun 2025 · 0 likes Picking up post #69: that is the part I would want checked first. Body image and weight loss: large weight loss changes a person's relationship with their body in ways…
-
Checking someone else's arithmetic: a worked example thread Replied, post #57 · Practice › Reconstitution · 14 Jun 2025 · 27 likes This follows post #54 rather than contradicting it. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration…
-
Managing an unplanned gap in supply — what changed since Started this topic · Access › Shortages · 11 Jun 2025 · 17 likes On the subject in the title: Managing an unplanned gap in supply — what changed since Working notes rather than a conclusion. A coverage question with the paperwork…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #4 · Analytics › HPLC & UHPLC · 4 Jun 2025 · 2 likes Worth separating two things that post #2 runs together. Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #105 · Data & Tools › Calculators · 1 Jun 2025 · 0 likes Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
-
Residual solvents and scavengers: what is looked for Replied, post #15 · Analytics › Impurities & related substances · 21 Apr 2025 · 14 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #5 · Analytics › Home & field testing · 8 Apr 2025 · 2 likes Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not…
-
Reading order for a first week here, and what to skip until later Replied, post #58 · Start Here › Welcome · 29 Mar 2025 · 1 like Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.
-
Charge states for a 4 kDa peptide, worked through Replied, post #39 · Analytics › Mass spectrometry · 7 Mar 2025 · 15 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #80 · Sourcing › Regulatory · 3 Mar 2025 · 1 like Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
-
Distinguishing a deletion sequence by mass alone Replied, post #13 · Analytics › Mass spectrometry · 23 Jan 2025 · 14 likes This follows post #10 rather than contradicting it. Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge…
-
What we do not know about retatrutide, listed explicitly Replied, post #60 · Compounds › Retatrutide · 18 Jan 2025 · 30 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #8 · Outcomes › Progress reports · 16 Jan 2025 · 0 likes I read post #6 twice before replying, because I had assumed the opposite. Exercise volume changes: increasing exercise intensity or duration can mask weight loss…
-
Second pass at: Regression to the mean in progress reports Replied, post #15 · Research Methods › Statistics · 3 Jan 2025 · 6 likes post #14 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
What changed in 2026, by region Replied, post #54 · Access › International · 2 Jan 2025 · 8 likes Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change.
-
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #15 · Devices › Syringes & needles · 2 Jan 2025 · 0 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #108 · Analytics › Method validation · 1 Jan 2025 · 20 likes Coming back to post #106, because the follow-up matters more than the original answer. Limits of detection and quantitation: LOD is the lowest concentration that…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #28 · Compounds › Oral incretins · 26 Dec 2024 · 25 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #6 · Compounds › Semaglutide · 15 Dec 2024 · 11 likes Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach empties it feeds less food into the intestines at a time,…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #46 · Practice › Side effects · 4 Dec 2024 · 3 likes Picking up post #43: that is the part I would want checked first. Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #52 · Compounds › Semaglutide · 28 Nov 2024 · 5 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
A promotion I argued against, and why I lost Replied, post #6 · Documentation › Doc review · 15 Nov 2024 · 15 likes Citation checking: if a maintained page cites a paper, the citation should match what the paper actually says. If you notice a mismatch, post it here.
-
US compounding rules and how they changed Replied, post #46 · Regional › North America · 29 Oct 2024 · 0 likes post #45 answers the question as asked. The question underneath it is different. Provincial formularies in Canada are published and are the correct source for coverage…
-
Converting between mg/mL and units per dose, both directions Replied, post #63 · Practice › Reconstitution · 25 Oct 2024 · 7 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #94 · Clinical › Comorbidities · 24 Oct 2024 · 16 likes Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more frequent on treatment. Histological resolution is a surrogate…
-
Turnaround times and what they mean for a decision — one year on Replied, post #4 · Sourcing › Independent verification · 28 Sep 2024 · 12 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #55 · Practice › Dosing & titration · 21 Jul 2024 · 4 likes On post #51 — agreed on the reasoning, with one qualification. How the published trials escalated: they used specific step sizes and intervals. The STEP programme used…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #10 · Evidence › Preprints · 24 Jun 2024 · 9 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…